Search clinical trials for: ZR202-CoV

Total 4593 results

Karolinska University Hospital

Completed

Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare

SARS-CoV 2

Sweden
Beijing Minhai Biotechnology Co., Ltd
Shenzhen Kangtai Biological Products Co., LTD; Jiangsu Province Centers for...

Unknown

A Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

COVID-19

China
Shanghai Zerun Biotechnology Co.,Ltd
Walvax Biotechnology Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19

COVID-19

China
Stanford University

Completed

Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)

Covid19

Australia
Ihsan GURSEL, PhD, Prof.
The Scientific and Technological Research Council of Turkey; MonitorCRO; Dr Abdurrahman... and other collaborators

Completed

Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults (COVID-19)

Covid19

Turkey
Illumina, Inc.
Helix OpCo, LLC

Completed

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

SARS-CoV-2

United States
Central Hospital, Nancy, France
University of Lorraine; Métropole du Grand Nancy

Completed

Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19) (COVAL-NANCY)

Coronavirus Infection | Prevalence

France
Novavax

Active, not recruiting

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years (COVID-19)

COVID-19

Spain, United States, South Africa, Mexico, United Kingdom, Philippines, Colombia, Dominican Republic, Guatemala, Honduras
Beijing Minhai Biotechnology Co., Ltd
Shenzhen Kangtai Biological Products Co., LTD; Jiangsu Province Centers for...

Unknown

A Study to Evaluate Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 18 Years and Above(COVID-19)

COVID-19

China
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

COVID-19

United States, Colombia, Ghana, Honduras, India, Japan, Kenya, Mexico, Nepal, Nigeria, Sri Lanka, Uganda, Ukraine
Moscow Department of Health
Moscow State University of Medicine and Dentistry; National Research Center... and other collaborators

Completed

The Evaluation of Cellular and Humoral Immunity to COVID-19 in Moscow Residents

Covid19 | Respiratory Viral Infection

Russian Federation
AIM Vaccine Co., Ltd.
Ningbo Rongan Biological Pharmaceutical Co. Ltd.; LiveRNA Therapeutics Inc.

Not yet recruiting

Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants

SARS-CoV-2
Laboratorio Elea Phoenix S.A.
China National Biotec Group Company Limited; Beijing Institute of Biological... and other collaborators

Completed

Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVID-19)

COVID-19 Virus Infection

Argentina
PT Bio Farma

Not yet recruiting

Homologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine

COVID-19
Butantan Institute

Not yet recruiting

Clinical Trial for Assessment of Anti-SARS-CoV-2 Serum for Early Treatment of COVID-19 Cases (SOROCOV)

Cardiovascular Diseases | COVID-19 | Diabetes Mellitus | Cancer | Chronic Obstructive Pulmonary Disease | Chemotherapy | Immunosuppression | Renal Disease | Other Complication of Kidney Transplant

Brazil
Ruijin Hospital

Recruiting

Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers

Covid19 | SARS-CoV-2 Infection

China
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Completed

Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above (COVID-19)

COVID-19 | COVID-19 Pneumonia

United Arab Emirates
Direction Centrale du Service de Santé des Armées
University Hospital, Grenoble

Terminated

Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. (PLASCOSSA)

COVID-19

France
Temple University
Patient-Centered Outcomes Research Institute

Recruiting

The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)

Hypertension | Obesity | Pregnancy Related | Racism

United States
Cancer Institute and Hospital, Chinese Academy...
Hubei Provincial Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

SARS-CoV-2 Infection

China
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

SARS-CoV-2 Infection

China
Immuno Cure 3 Limited
The University of Hong Kong

Active, not recruiting

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

COVID-19

Hong Kong
Emory University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Multisite Observational Maternal and Infant Study for COVID-19 (MOMI-Vax)

COVID-19

United States
Assistance Publique - Hôpitaux de Paris

Completed

Prevalence and Impact of COVID-19 Infection in Pregnant Women, Fetuses and Newborns (COVIPREG)

Pregnancy

France
Grand Hôpital de Charleroi

Completed

Monitoring of COVID-19 Seroprevalence Among GHdC Staff Members

Covid19

Belgium
Al-Azhar University
Ain Shams University; South Valley University; Helwan University; National Liver...

Completed

Non-invasive Predictors of ICU Admission and Mortality in Initially Asymptomatic COVID-19 Patients (COVID-HRCT)

COVID-19

Egypt
Fundação de Medicina Tropical Dr. Heitor Vieira...
Butantan Institute

Active, not recruiting

Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity (COVACMANAUS)

Covid19

Brazil
Assistance Publique - Hôpitaux de Paris
PRODISS; WEEZEVENT

Completed

Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event (SPRING)

Covid19

France
Sinovac Biotech Co., Ltd

Active, not recruiting

Safety and Immunogenicity Study of Booster Vaccination With Medium-dosage or High-dosage SARS-CoV-2 Inactivated Vaccine for Prevention of COVID-19

COVID-19

China
Novavax

Not yet recruiting

Phase 3 Strain Change Study for SARS-CoV-2 rS Vaccines (COVID-19)

Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection

China
Centre Hospitalier Universitaire de Nīmes

Active, not recruiting

Effect of a Vaccination Against COVID-19 on Monocyte Production of Oxygenated Derivatives. (VACTICOV2)

CORONAVIRUS INFECTIONS

France
Institut de Formation et de Recherche en Médecine...
University of Paris 13; Ecole Nationale des Sports de Montagne

Completed

Coronaltitude - Multicentric Evaluation of the Impact on Hypoxia Sensitivity of Patients With COVID-19 (CORONALTITUDE)

Covid19 | SARS-CoV2 Infection | Hypoxia, Altitude

France
Assistance Publique - Hôpitaux de Paris

Completed

Epidemiological Characteristics of COVID-19 in Patients With MS or NMO (COVISEP)

COVID-19 | Multiple Sclerosis | NMO Spectrum Disorder

France
PT Bio Farma
Universitas Padjadjaran

Active, not recruiting

Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years of Age

COVID-19

Indonesia
PT. Kimia Farma (Persero) Tbk

Active, not recruiting

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

COVID-19

Indonesia
Kingman Regional Medical Center

Completed

Prevalence of COVID-19 Antibodies Kingman AZ

Covid19

United States
Ihsan GURSEL, PhD, Prof.
The Scientific and Technological Research Council of Turkey; MonitorCRO; Nobel...

Completed

Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine (COVID-19)

Covid19

Turkey
Meissa Vaccines, Inc.

Recruiting

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

Covid19

United States
John Sampson

Completed

Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer (ERaDICATe)

Glioblastoma

United States
University of Utah

Completed

A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy

Pneumoperitoneum

United States
Universidad de Antioquia
Laboratorio integrado de medicina especializada(LIME); Proyecto de regalias...

Recruiting

Prospective Evaluation of SARS-CoV-2 Antibodies Levels in a Vaccinated Population of Valle de Aburra

COVID-19

Colombia
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd; Hunan Provincial Center for Disease...

Not yet recruiting

Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19

China
AIM Vaccine Co., Ltd.
First Affiliated Hospital Bengbu Medical College

Active, not recruiting

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

SARS-CoV-2

China
Novindiet Clinic
Tehran University of Medical Sciences; University of Nottingham

Completed

Effectiveness of Online Visit Compared With In-person Clinic Visit on Weight Loss

Obesity | Overweight

Iran, Islamic Republic of
University Hospital, Geneva

Completed

Evaluation of the Safety and Outcomes of Outpatient Management With Mild to Moderate COVID-19 Pneumonia (PneumoCoV-Ambu)

Pneumonia | Covid19

Switzerland
Fundación Santa Fe de Bogota

Unknown

Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19

Covid-19 | Sars-CoV2

Colombia
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd; Hunan Provincial Center for Disease...

Not yet recruiting

Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19

China
Shenzhen Kangtai Biological Products Co., LTD
Beijing Minhai Biotechnology Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19)

COVID-19
University Medical Center Groningen

Active, not recruiting

Vaccination Against COVID-19 in Cancer (VOICE)

Cancer

Netherlands

Search clinical trials for: ZR202-CoV

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations